PPD Inc., of Wilmington, N.C., has named Andy Strayer senior vice president of clinical operations for the Americas and Asia; Sue Stansfield senior vice president of clinical operations and project management for Europe; Mark Roseman vice president for clinical operations; and Randy Marchbanks vice president of business development for the Americas.
Protox Therapeutics Inc., of Vancouver, British Columbia, said James Beesley is joining the company as director of investor relations.
RegImmune Corp., of Mountain View, Calif., and Tokyo, appointed Shirley Liu Clayton as a nonexecutive director.
Sequenom Inc., of San Diego, appointed Paul Hawran chief financial officer.
Solazyme, of Menlo Park, Calif., has named Donald E. Trimbur senior director of biofuel development.
Stellar Pharmaceuticals, of London, Ontario, has appointed John M. Gregory, CEO of King Pharmaceuticals, a new director.
TaiGen Biotechnology Inc., of Taipei, Taiwan, appointed Luke Lin vice president of clinical research and development.
Tapestry Pharmaceuticals Inc., of Boulder, Colo., appointed Sandra Silberman chief medical officer.
Transgenomic Inc., of Omaha, Neb., has appointed Rodney S. Markin to its board of directors.
Ventures West, of Vancouver, British Columbia, said Kenneth Galbraith joined the firm as venture partner.
VIRxSYS Corp., of Gaithersburg, Md., said Gerard McGarrity joined the company as executive vice president of scientific and clinical affairs.